Premier Medical Laboratory Services (PMLS) has announced the impending release of their Coronavirus (COVID-19) test for hospitals and physician offices throughout the United States. Their COVID-19 test has been developed using the CDC’s guidelines and is currently under FDA review for Emergency Use Authorization (EUA) to start patient sample testing at the conclusion of the validation process in a couple of days.
The PMLS molecular diagnostic test utilizes a nasal pharyngeal swab to determine the presence of COVID-19 in a matter of 1-2 days. Rapid testing is paramount to the response efficiency of the health care system and the employment of appropriate containment strategies of the virus.
In a statement made by PMLS, “We take pride in our laboratory services being at the forefront of the most advanced technology and science available, providing cutting edge diagnostics to healthcare providers and their patients. Our team of scientists are working diligently to provide the utmost efficiency in COVID-19 testing so that the growing number of cases can be stabilized and the virus can be contained.”